CYduct Diagnostics, Inc.
CYDX
$0.498
$0.012.05%
OTC PK
| 03/31/2012 | 12/31/2011 | 09/30/2011 | 06/30/2011 | 03/31/2011 | |
|---|---|---|---|---|---|
| Revenue | -14.89% | -23.47% | -25.40% | -9.31% | -6.10% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -14.89% | -23.47% | -25.40% | -9.31% | -6.10% |
| Cost of Revenue | 24.84% | 12.79% | -61.72% | -50.78% | -52.38% |
| Gross Profit | -29.35% | -37.52% | 15.65% | 41.00% | 45.21% |
| SG&A Expenses | -56.42% | -22.48% | 57.35% | 39.19% | 50.25% |
| Depreciation & Amortization | -71.43% | -57.60% | -40.20% | -31.03% | -23.91% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -51.68% | -20.45% | 32.19% | 22.64% | 31.27% |
| Operating Income | 62.58% | 19.33% | -64.78% | -36.53% | -48.79% |
| Income Before Tax | 109.72% | 57.75% | 54.61% | 45.24% | 42.26% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 109.72% | 57.75% | 54.61% | 45.24% | 42.26% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 109.72% | 57.75% | 54.61% | 45.24% | 42.26% |
| EBIT | 62.58% | 19.33% | -64.78% | -36.53% | -48.79% |
| EBITDA | 62.64% | 18.37% | -69.18% | -38.79% | -51.38% |
| EPS Basic | -- | -- | -- | -- | -- |
| Normalized Basic EPS | -- | -- | -- | -- | -- |
| EPS Diluted | -- | -- | -- | -- | -- |
| Normalized Diluted EPS | -- | -- | -- | -- | -- |
| Average Basic Shares Outstanding | -- | -- | -- | -- | -- |
| Average Diluted Shares Outstanding | -- | -- | -- | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |